The global Insulin Glargine Market is estimated to be valued at US$ 6,153.5 Mn in 2021 and is expected to exhibit a CAGR of 0.2% over the forecast period (2022-2028), as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
Insulin glargine is a long-acting insulin used to treat type 1 and type 2 diabetes. It provides a steady level of insulin in the body, helping to control blood sugar levels throughout the day and night. Insulin ... Read more
